FDA Approves First New Influenza Drug in 20 Years

Patients who contract influenza this season will have a new treatment option—if they seek it out in time. The recently approved drug Xofluza has a different mechanism of action and requires just one pill. While that’s good news, the best way to combat influenza remains getting a vaccine. This year, a favorite of needle-shy patients returns as an option, and the vaccine appears well suited to circulating strains. Read more.

Diabetes Services: A Sweet Spot for Pharmacists

One in 10 Americans has diabetes, and that number is expected to rise sharply over the coming decade. As the healthcare   professionals who see these patients the most often, pharmacists can improve care for this sizable population and increase revenues by offering diabetes-related services and supplies. Helping at-risk patients keep from developing  diabetes provides opportunities, too. Read more.